DR. JASWANT S. JADEJA, MD

JACKSONVILLE, FL

Research Active
Internal Medicine - Hematology & Oncology NPI registered 21+ years 3 publications 1987 – 2021 NPI: 1306841622
NeoplasmsAntineoplastic AgentsThrombosisAnemiaInjections, SubcutaneousCatheterizationHemoglobinsDarbepoetin alfaErythropoietinAxillary VeinInfusions, IntravenousCatheters, IndwellingBlood Coagulation TestsSubclavian VeinUrokinase-Type Plasminogen Activator

Practice Location

5742 BOOTH RD
JACKSONVILLE, FL 32207-5905

Phone: (904) 739-7779

What does JASWANT JADEJA research?

Dr. Jadeja studies various approaches to treat conditions related to the neck and spine, particularly through surgical methods that involve accessing the spine from the front of the neck. He has also researched effective treatments for chemotherapy-induced anemia, comparing different ways to administer medication to improve patients' blood levels. Additionally, he investigates how to help cancer patients experiencing blood clots related to the use of central venous catheters.

Key findings

  • In a study on surgical methods for neck issues, one approach showed only a 7% rate of complications, demonstrating its safety and effectiveness.
  • In research on anemia, patients receiving subcutaneous injections of darbepoetin alfa had an average hemoglobin increase of 1.3 g/dl, while those receiving intravenous infusions saw an increase of 1.1 g/dl, with 82% and 80% maintaining their hemoglobin levels, respectively.
  • A treatment with urokinase successfully dissolved 25 out of 30 blood clots in cancer patients, with an 81% resolution rate for those with symptoms for less than a week.

Frequently asked questions

Does Dr. Jadeja study treatments for cancer-related anemia?
Yes, he researches methods to treat anemia caused by chemotherapy, specifically investigating the administration of darbepoetin alfa.
What surgical methods does Dr. Jadeja focus on?
He focuses on surgical procedures for neck and spine issues, particularly using an anterior approach that has shown positive patient outcomes.
Is Dr. Jadeja's work relevant for cancer patients with blood clots?
Absolutely, he researches treatments to dissolve blood clots in cancer patients, improving their treatment and recovery options.

Publications in plain English

Anterior Approach to the Cervical Spine: Elegance Lies in Its Simplicity.

2021

Asian journal of neurosurgery

Arumalla K, Bansal H, Jadeja J, Batish A, Deora H +3 more

Plain English
This study looked at different surgical methods for treating problems in the neck and spine using an approach from the front of the neck. Researchers analyzed outcomes from various case studies, finding that most patients had good results after surgery. Specifically, one method showed a 7% rate of complications like cerebrospinal fluid leaks, while another method called anterior cervical discectomy and fusion (ACDF) worked well even for complicated cases. Who this helps: This helps patients with neck and spine issues and the doctors treating them.

PubMed

A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia.

2005

Annals of oncology : official journal of the European Society for Medical Oncology

Justice G, Kessler JF, Jadeja J, Campos L, Weick J +3 more

Plain English
This study looked at two ways to give a medication called darbepoetin alfa to treat anemia caused by chemotherapy: through an intravenous (i.v.) infusion and a subcutaneous (s.c.) injection. In six weeks, hemoglobin levels increased by an average of 1.1 g/dl for the i.v. group and 1.3 g/dl for the s.c. group. Both methods were found to be effective and safe, with similar results; around 82% of patients on i.v. and 80% on s.c. maintained their hemoglobin levels during the following treatment period. Who this helps: This benefits cancer patients experiencing anemia from chemotherapy.

PubMed

Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients.

1987

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Fraschini G, Jadeja J, Lawson M, Holmes FA, Carrasco HC +1 more

Plain English
Researchers studied how effective a treatment called urokinase is for dissolving blood clots in cancer patients who had central venous catheters. They found that the treatment successfully dissolved 25 out of 30 blood clots within about four days. The results show that patients who have symptoms for less than a week are more likely to have their clots resolved (81%) compared to those with symptoms for longer (56%). Who this helps: This benefits cancer patients who require central venous catheters and may develop blood clots.

PubMed

Frequent Co-Authors

Kirit Arumalla Hanish Bansal Aman Batish Harsh Deora Manjul Tripathi Sandeep Mohindra Sanjay Behari G Justice J F Kessler L Campos

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.